Position in VRTX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,315,755
+$1,680,329 QoQ
Shares Held
4,662
+227.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#633
of 1,732 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 68%
Shared 0%
None 32%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Arax Advisory Partners holds $59,653,938 across 287 Biotechnology names. VRTX ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
118,402 | $13,422,050 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,563 | $5,962,913 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,844 | $4,167,459 | |
| 4 | EXEL |
Exelixis, Inc.
|
70,160 | $3,817,405 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
66,469 | $2,592,955 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
4,662 | $2,315,755 | |
| 7 | MESO |
Mesoblast Ltd
|
168,022 | $2,273,337 | |
| 8 | FTRE |
Fortrea Holdings Inc.
|
88,116 | $1,533,218 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,315,755 | 4,662 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $635,426 | 1,423 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $895,839 | 1,976 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $641,897 | 1,639 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $455,439 | 1,023 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $498,394 | 1,028 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $745,397 | 1,851 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $165,568 | 356 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $163,114 | 348 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $23,408 | 56 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $22,785 | 56 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $19,473 | 56 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $19,706 | 56 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $16,068 | 51 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $10,973 | 38 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $10,133 | 35 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $12,680 | 45 | Shares | Sole | 2022-08-22 | |
| 2022-03-31 | $5,741 | 22 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $10,980 | 50 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $11,790 | 65 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $12,097 | 60 | Shares | Sole | 2021-08-02 | |
| 2020-12-31 | $15,125 | 64 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $16,327 | 60 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $17,418 | 60 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $14,277 | 60 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||